Since more than half of patients with HCC display elevated AFP expression, we aimed to expand the potential application of the AFP vaccine combination immunotherapy strategy for AFP(+) HCC driven by other oncogenes. The gene discussed is AFP; the disease is hepatocellular carcinoma.